New immunisation reference page- Guillain-Barre Syndrome
Guillain-Barre Syndrome is an autoimmune condition resulting in muscle weakness, altered sensation, numbness and paralysis. It is often triggered by a viral or bacterial infection however there is also variable evidence suggesting an association with influenza vaccination.
For further information and immunisation recommendations please refer to MVEC's new immunisation reference page
Influenza vaccine 2019- FAQ's
MVEC's Frequently Asked Questions for the 2019 Influenza season are now available online
To view our reference page please click on the following link:
Avoiding shoulder injury related to vaccine administration
Shoulder injury related to vaccine administration (SIRVA) describes a complication of incorrect immunisation technique whereby a vaccine is injected too high above the deltoid muscle. Implications of SIRVA include persisting pain and limited range of movement, uncertain seroprotection due to the incorrect site of administration, as well costly outcomes for the patient due to diagnostic imaging and interventions.. For tips on avoiding SIRVA please refer to the following resources:
MVEC: Shoulder injury related to vaccine administration
MVEC：注射疫苗的管理 - 正确的技术
Australian Immunisation Handbook: avoiding shoulder injury related to vaccine administration
New immunisation reference page- Pharmacist immunisers
Pharmacist immunisers are registered pharmacists who are accredited to administer approved immunisations to specified patient groups within the community. For further information on the role of pharmacist immunisers as well as the approved training programs, please refer to:
2019 Influenza vaccine recommendations
For information on influenza immunisation for the 2019 season, including age specific brands, dosing guidelines and advice for at risk groups, please refer to:
Influenza and pertussis vaccination in pregnancy
Antenatal immunisation with Influenza and pertussis (whooping cough) vaccines are strongly recommended in every pregnancy to protect both the mother and baby from disease and its complications. Evidence around the timing of pertussis immunisation in pregnancy has recently been reviewed and it is now recommended that a pertussis containing vaccine be administered between 20 and 32 weeks of the pregnancy. Immunisation is provided free to all pregnant women through the National Immunisation Program.
For further information about maternal vaccination recommendations visit our reference page 墨尔本疫苗教育中心（MVEC）：孕期孕妇疫苗接种
Updated resources for Aboriginal and Torres Strait Islander patients
An updated immunisation reference page is now online for Aboriginal and Torres Strait Islander people. This new page also details the latest recommendations for meningococcal immunisation in this population group. From 2019 Influenza vaccination will be funded for all people from 6-months of age. To view the page please follow the link below:
Aboriginal and Torres Strait Islander immunisation recommendations
Updated maternal immunisation resources
Monash Health immunisation have recently updated their patient information brochures regarding Influenza and Pertussis vaccination during pregnancy. Please find these updated resources via our reference page below:
Spleen Australia- updated guidelines 2019
Spleen Australia have recently updated their medical recommendations for asplenic/hyposplenic adults and children. These guidelines also detail additional immunisation recommendations, including updated information on booster doses for pneumococcal and meningococcal vaccines in this patient group.
Please refer to our MVEC page for more information MVEC：阿斯普利亚
New meningococcal resources
这 澳大利亚科学院 has released a new video detailing the devastating impact of meningococcal disease.
To access this video, as well as other meningococcal information, please follow the link below: